Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • National Collegiate Rugby Files Lawsuit Against USA Rugby
    National Collegiate Rugby Files Lawsuit Against USA Rugby World News
  • Building a New American Workforce that Taps into the Limitless Potential of Women
    Building a New American Workforce that Taps into the Limitless Potential of Women Business
  • LiveHire and Career Money Life Launch Innovative Candidate Experience Solution
    LiveHire and Career Money Life Launch Innovative Candidate Experience Solution Business
  • Logistics Plus Philippines Achieves Certification of Registration for SEHQ Excellence
    Logistics Plus Philippines Achieves Certification of Registration for SEHQ Excellence Business
  • DHS and DOJ Propose Rule to Incentivize Lawful Migration Processes
    DHS and DOJ Propose Rule to Incentivize Lawful Migration Processes World News
  • War Day 48 :: war chronicles with Advisor to Ukraine President, Intel Officer, Alexey Arestovych
    War Day 48 :: war chronicles with Advisor to Ukraine President, Intel Officer, Alexey Arestovych World News
  • Joint Statement on the Strategic Dialogue Between the United States and Poland
    Joint Statement on the Strategic Dialogue Between the United States and Poland World News
  • Single Digits Celebrated Its 20-Year Anniversary
    Single Digits Celebrated Its 20-Year Anniversary Business
Envision Pharma Group Acquires OKRA.ai

Envision Pharma Group Acquires OKRA.ai

Posted on February 7, 2023 By NewsEditor
Envision Pharma Group Acquires OKRA.aiEnvision Pharma Group Acquires OKRA.aiPivotal acquisition in Envision Pharma Group's tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products' path to market and ultimately supports the delivery of enhanced patient outcomes.

PHILADELPHIA, February 7, 2023 (Newswire.com) - Envision Pharma Group (Envision), a leading global technology-enabled commercialization, integrated medical capabilities and solutions, and data analytics partner to the life sciences industry, announced today it has acquired OKRA.ai, an award-winning technology company active in the provision of artificial intelligence (AI) solutions with present brains across commercialization, real-world evidence and data analytics, medical, and pricing for the pharmaceutical and life sciences industry. 

OKRA.ai's AI products and solutions translate large clinical, scientific, and commercial data sets into actionable insights to empower decision-making and drive action to clients in the life sciences industry.

"We are delighted to welcome OKRA.ai into the Envision Pharma Group family," shares Meg Heim, CEO, Envision Pharma Group. "The acquisition of OKRA.ai marks an exciting milestone in Envision's evolution as we continue to accelerate and deliver a compelling combination of technology-enabled capabilities and solutions to clients. The combination of Envision's leading technology, capabilities, and solutions with OKRA.ai's artificial intelligence solutions and expertise enables us to strengthen our offerings to clients across the product life cycle, but more importantly, support patients in their journey to health and wellness."  

Dr. Loubna Bouarfa, founder of OKRA.ai, will be joining Envision as a member of its Executive Leadership Team. Recently, Loubna won the prestigious Deloitte Fast 50 Women in Leadership Award and Forbes 50 Top Women in Tech. Loubna shares, "Today is a redefining moment for OKRA.ai. I am honored to be joining forces with Envision and see enormous opportunities for the growth of our combined expertise and solutions for clients in the life sciences industry. As part of Envision Pharma Group, we can accelerate our work to bring AI to the heart of decision-making across the life sciences industry. Our success will not only bring commercial benefit to clients but lead to improved patient outcomes across the globe." 

Based in the U.K. and Netherlands, OKRA.ai employs around 30 members of staff. The acquisition of OKRA.ai will bring the total number of Envision Pharma Group to 1,400+ employees across four continents.  

About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product lifecycle through a comprehensive suite of services and industry-leading technology solutions: including evidence-based scientific communications and engagement; commercialization and integrated medical consultancy; and HEOR/market access and data analytics capabilities. Learn more at www.envisionpharmagroup.com

About OKRA.ai 
OKRA.ai is a pioneer in developing AI solutions for the life sciences industry, bringing self-learning AI to optimize commercial, medical and market access decision making. Through its product portfolio, OKRA.ai delivers AI solutions to empower pharmaceutical companies with predictions and suggestions to bring novel treatments to patients in an efficient and effective way. 

OKRA.ai was founded by Dr. Loubna Bouarfa in 2015 with a vision of moving the healthcare industry towards data-driven decision-making by explainable AI. Since then, OKRA.ai has been instrumental in building industry-first Explainable AI which empowers users by providing explanations behind predictions and suggestions. OKRA.ai currently consists of a highly qualified workforce across the UK and the Netherlands and has a nearly equal gender balance (48% of staff are female). 

OKRA.ai's solution suite compiles healthcare data from multiple sources, with coverage across hundreds of therapeutic areas, thousands of clinical trials and publications, millions of medically relevant free text and billions of data points that are specific to patient demographics. Since 2015, OKRA.ai has supported the commercialization of 92 molecules, 67 indications and 13 pharmaceutical brands.

Contact Information:
Colleen Carter
Communications
[email protected]
1 (203) 480 0080


Original Source: Envision Pharma Group Acquires OKRA.ai Envision Pharma Group Acquires OKRA.ai
Business

Post navigation

Previous Post: Under Secretary Zeya’s Travel to Ulaanbaatar, Mongolia and Tokyo, Japan
Next Post: General Communication Equipment Market Size, Share And Growth Analysis For 2023-2032

Related Posts

  • Digital Additive Named #1 Best Place for Women to Work in Atlanta
    Digital Additive Named #1 Best Place for Women to Work in Atlanta Business
  • GGE Announces the Appointment of a CEO of Its US Subsidiary to Lead the Effort to Explore Green Energy Sector
    GGE Announces the Appointment of a CEO of Its US Subsidiary to Lead the Effort to Explore Green Energy Sector Business
  • Building a New American Workforce that Taps into the Limitless Potential of Women
    Readout of Deputy Secretary Don Graves Meeting with Puerto Rico Financial Oversight and Management Board Executive Director Robert Mujica Business
  • AIM Enterprises Expands Inventory to Include Top-Quality Used Picture Framing Equipment
    AIM Enterprises Expands Inventory to Include Top-Quality Used Picture Framing Equipment Business
  • Winegard Adds Flat High-Performance Starlink to Its Offerings for RVs, Providing High-Speed, Low-Latency Internet on the Go
    Winegard Adds Flat High-Performance Starlink to Its Offerings for RVs, Providing High-Speed, Low-Latency Internet on the Go Business
  • PAIRIN Acquires Savviest, Bringing AI-Driven Resume and Cover Letter Technology to the My Journey Platform
    PAIRIN Acquires Savviest, Bringing AI-Driven Resume and Cover Letter Technology to the My Journey Platform Business
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • The Global Games Show 2025, hosted by VAP Group with Abu Dhabi Convention & Exhibition Bureau, Returns for 3rd EditionOctober 9, 2025
  • Antibody Production Market Outlook 2025–2035October 9, 2025
  • Franchise Development Service Market to Reach USD $10.94 Billion by 2029 at 9.4% CAGROctober 9, 2025
  • Financial Outsourcing Services Market to Reach $74.72 Billion by 2029 with 8.3% CAGROctober 8, 2025
  • Fairhope Aerospace Earns SBA Veteran-Owned Small Business CertificationOctober 8, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • nogaholding Partners With GHGSat for High-Resolution Satellite Data
    nogaholding Partners With GHGSat for High-Resolution Satellite Data Business
  • War Day 80: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин
    War Day 80: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин World News
  • Bexar County Property Tax Binding Arbitration and Lawsuits
    Bexar County Property Tax Binding Arbitration and Lawsuits Business
  • A Trusted Fiduciary Authority with 41 Years of Experience.
    A Trusted Fiduciary Authority with 41 Years of Experience. Business
  • Day 353: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    Day 353: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Following More Than a Decade of Development, TM Technologies Demonstrates More Than 50% Increase in Data Efficiency for Telecom
    Following More Than a Decade of Development, TM Technologies Demonstrates More Than 50% Increase in Data Efficiency for Telecom Business
  • Tech Visionary Kerry W. Kirby Delivers Bold Insights on The New Frontier of AI Digital Discovery in Must-Hear Podcast
    Tech Visionary Kerry W. Kirby Delivers Bold Insights on The New Frontier of AI Digital Discovery in Must-Hear Podcast World News
  • Construction Chemicals Market Size Expected To Reach .77 Billion By 2028
    Construction Chemicals Market Size Expected To Reach $77.77 Billion By 2028 World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .